MorphoSys AG (MOR)
Aug 5, 2024 - MOR was delisted (reason: voluntary delisting)
18.96
+0.45 (2.43%)
Inactive · Last trade price
on Aug 2, 2024
MorphoSys AG Employees
MorphoSys AG had 524 employees as of December 31, 2023. The number of employees decreased by 105 or -16.69% compared to the previous year.
Employees
524
Change (1Y)
-105
Growth (1Y)
-16.69%
Revenue / Employee
$505,255
Profits / Employee
-$402,320
Market Cap
2.86B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 524 | -105 | -16.69% |
Dec 31, 2022 | 629 | -103 | -14.07% |
Dec 31, 2021 | 732 | 117 | 19.02% |
Dec 31, 2020 | 615 | 189 | 44.37% |
Dec 31, 2019 | 426 | 97 | 29.48% |
Dec 31, 2018 | 329 | 3 | 0.92% |
Dec 31, 2017 | 326 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
MOR News
- 5 hours ago - Novartis: launch of Morphosys drug by could be 2027 or later - Reuters
- 3 months ago - Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting - Accesswire
- 4 months ago - MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market - Business Wire
- 5 months ago - MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys' Minority Shareholders - Business Wire
- 5 months ago - Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG's Minority Shareholders - Accesswire
- 6 months ago - Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash - GlobeNewsWire
- 7 months ago - MorphoSys: Hold Rating Until The Novartis Deal Closes - Seeking Alpha
- 7 months ago - MorphoSys AG Reports First Quarter 2024 Financial Results - Business Wire